Skip to Content

quinuclidinyl benzilate

Pronunciation: kwi-nuk'li-din'il ben'zi-lat

Definition: A highly potent anticholinergic agent exhibiting 50- to 100-fold greater potency over atropine in binding with and blocking muscarinic cholinergic receptors. Originally developed as a potential military incapacitating agent, it is currently extensively used as a radioactive agent (usually tritiated —H3 —QNB) to identify and label muscarinic receptors in pharmacologic studies.

Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.
© Copyright 2017 Wolters Kluwer. All Rights Reserved. Review Date: Sep 19, 2016.
Hide